companydata.dkcompanydata.dk

HHR HOLDING A/S: Financial statements 2025

CVR: 14010882

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

HHR HOLDING A/S (CVR 14010882) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -871,497 and a net result of DKK -507,597 compared with DKK 3,407,997 the year before. Equity in the 2025 report amounted to DKK 16,019,899. The solvency ratio was 78%.

Gross Profit
DKK -871,497
Profit/Loss
DKK -507,597
Equity
DKK 16,019,899
Total Assets
DKK 20,539,058
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--871K-508K16M0
20240-605K3.4M16.8M1
20230-2.6M-3.9M13.3M1
2022--703K-3.3M16M2
2021--1M1.4M19.3M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is HHR HOLDING A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

HHR HOLDING A/S: The 2024 annual report is outJan 22, 2025

HHR HOLDING A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 3,407,997.

About HHR HOLDING A/S

HHR HOLDING A/S is a Danish company of the type Aktieselskab based in Rungsted Kyst, founded in 1990. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named UNITED NORDIC PHARMA A/S and UNITED NORDIC PHARMA ApS. The management consists of Hans Henrik Raith. The board consists of Jörn Rolander (chair), Hanne Kvistgaard Raith and Hans Henrik Raith. The company is owned by Hans Henrik Raith. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -871,497 and a net result of DKK -507,597 compared with DKK 3,407,997 the year before. Equity in the 2025 report amounted to DKK 16,019,899.

Source: annual report 2025, Danish Business Authority